Seeking Alpha

parkavemom

parkavemom
Send Message
View as an RSS Feed
Latest  |  Highest rated
  • Illumina (ILMN) CEO Jay Flatley tells Bloomberg that while the fiscal cliff will affect a third of the gene-sequencing company's customers, "it's going to probably be pretty short-lived." Flatley also says that Roche going public in January with its $6.7B offer for Illumina stopped the board from properly discussing the offer and possibly put paid to the deal. [View news story]
    Learn how to spell or stop typing when your drinking and make a direct point.

    As far as I know from scientists in the field, Illumina still holds the high standard above the other companies.
    Sep 21, 2012. 12:12 AM | Likes Like |Link to Comment
COMMENTS STATS
1 Comment
0 Likes